OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
000822$5.4556

Shandong Haihua Co Ltd

Commodity ChemicalsVerified

Shandong Haihua's capital structure is characterized by a debt-to-equity ratio of 0.64, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.79, suggesting that it may struggle to meet short-term obligations with its current assets. The company's price-to-book ratio of 1.27 implies that the market values the company slightly above its book value, while the price-to-tangible-book ratio is identical, indicating no significant intangible assets. Profitability metrics for Shandong Haihua are weak, with a return on equity of -0.3624 and a return on assets of -0.1569, both significantly below the industry median for Commodity Chemicals. The company reported a net loss of CNY 1.39 billion, with operating income also in negative territory at CNY -1.32 billion. These figures suggest that the company is currently unprofitable and underperforming relative to its peers. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases exposure to regional economic and regulatory risks. No specific geographic breakdown is provided in the available data, but the company's operations are primarily based in China. Shandong Haihua's growth trajectory is negative, with a net loss in the most recent fiscal year and no indication of improvement in the outlook. The company's operating cash flow is negative at CNY -104.35 million, and free cash flow is also negative at CNY -1.23 billion. These figures suggest that the company is not generating sufficient cash to fund operations or reinvest in the business. The company's risk profile is elevated, with a medium liquidity risk and a negative operating cash flow. The risk assessment also flags that the company has negative net cash after subtracting total debt, which could lead to financial distress. The dilution risk is assessed as low, with no significant dilution potential reported in the basic shares outstanding. However, the company's capital expenditure of CNY -174.34 million indicates ongoing investment in infrastructure, which may increase leverage if funded through debt. Recent events include the company's latest financial filing, which discloses a significant net loss and negative operating income. No recent earnings call transcripts or major corporate announcements are available in the provided data. The company's financial performance is likely influenced by industry-wide challenges, such as raw material price volatility and weak demand for commodity chemicals.

30-day price · 000822(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyShandong Haihua Co Ltd
Ticker000822.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Shandong Haihua Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products in domestic and international markets.

Classification. Shandong Haihua is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92 based on verified market data.

Shandong Haihua's capital structure is characterized by a debt-to-equity ratio of 0.64, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.79, suggesting that it may struggle to meet short-term obligations with its current assets. The company's price-to-book ratio of 1.27 implies that the market values the company slightly above its book value, while the price-to-tangible-book ratio is identical, indicating no significant intangible assets. Profitability metrics for Shandong Haihua are weak, with a return on equity of -0.3624 and a return on assets of -0.1569, both significantly below the industry median for Commodity Chemicals. The company reported a net loss of CNY 1.39 billion, with operating income also in negative territory at CNY -1.32 billion. These figures suggest that the company is currently unprofitable and underperforming relative to its peers. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases exposure to regional economic and regulatory risks. No specific geographic breakdown is provided in the available data, but the company's operations are primarily based in China. Shandong Haihua's growth trajectory is negative, with a net loss in the most recent fiscal year and no indication of improvement in the outlook. The company's operating cash flow is negative at CNY -104.35 million, and free cash flow is also negative at CNY -1.23 billion. These figures suggest that the company is not generating sufficient cash to fund operations or reinvest in the business. The company's risk profile is elevated, with a medium liquidity risk and a negative operating cash flow. The risk assessment also flags that the company has negative net cash after subtracting total debt, which could lead to financial distress. The dilution risk is assessed as low, with no significant dilution potential reported in the basic shares outstanding. However, the company's capital expenditure of CNY -174.34 million indicates ongoing investment in infrastructure, which may increase leverage if funded through debt. Recent events include the company's latest financial filing, which discloses a significant net loss and negative operating income. No recent earnings call transcripts or major corporate announcements are available in the provided data. The company's financial performance is likely influenced by industry-wide challenges, such as raw material price volatility and weak demand for commodity chemicals.
Key takeaways
  • Shandong Haihua is currently unprofitable, with a net loss of CNY 1.39 billion and negative operating income.
  • The company's liquidity position is weak, with a current ratio of 0.79 and negative net cash after subtracting total debt.
  • Profitability metrics, including return on equity and return on assets, are significantly below industry medians.
  • The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.64.
  • Growth prospects are limited, with negative operating and free cash flows.
  • The company's risk profile is elevated, with medium liquidity risk and a low dilution risk.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$4.75B
Gross profit-$271.2M
Operating income-$1.32B
Net income-$1.39B
R&D
SG&A
D&A
SBC
Operating cash flow-$104.4M
CapEx-$174.3M
Free cash flow-$1.23B
Total assets$8.85B
Total liabilities$5.02B
Total equity$3.83B
Cash & equivalents
Long-term debt$2.43B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$4.75B-$1.32B-$1.39B-$1.23B
FY-1$6.01B$44.9M$39.2M$101.0M
FY-2$8.53B$1.35B$1.04B$1.08B
FY-3$9.71B$1.47B$1.11B$1.13B
FY-4$6.71B$1.03B$750.7M$914.9M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$8.85B$3.83B
FY-1$8.58B$5.20B
FY-2$8.05B$5.18B
FY-3$6.92B$4.16B
FY-4$6.24B$3.97B
PeriodOCFCapExFCFSBC
FY0-$104.4M-$174.3M-$1.23B
FY-1$1.66B-$161.8M$101.0M
FY-2-$333.6M-$185.4M$1.08B
FY-3$1.04B-$132.4M$1.13B
FY-4$829.6M-$29.4M$914.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$1.10B-$89.8M-$80.2M
FQ-1$1.18B-$792.8M-$991.4M
FQ-2$1.43B-$188.7M-$138.3M
FQ-3$1.11B-$245.5M-$191.4M
FQ-4$1.02B-$96.6M-$66.5M
FQ-5$1.19B-$176.3M-$132.6M
FQ-6$1.35B-$80.6M-$52.6M
FQ-7$1.63B$92.9M$68.7M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$8.97B$3.74B$2.03B
FQ-1$8.85B$3.83B
FQ-2$9.28B$4.80B$1.51B
FQ-3$8.37B$4.95B
FQ-4$8.48B$5.13B$2.24B
FQ-5$8.58B$5.20B
FQ-6$8.44B$5.27B$1.82B
FQ-7$8.30B$5.32B
PeriodOCFCapExFCFSBC
FQ0-$710.9M-$15.9M
FQ-1-$104.4M-$174.3M
FQ-2-$131.2M-$154.4M
FQ-3$346.2M-$132.1M
FQ-4$50.0M-$30.2M
FQ-5$1.66B-$161.8M
FQ-6$1.03B-$117.7M
FQ-7$763.1M-$100.4M
Valuation
Market price$5.45
Market cap$4.88B
Enterprise value$7.31B
P/E
Reported non-GAAP P/E
EV/Revenue1.5
EV/Op income
EV/OCF
P/B1.3
P/Tangible book1.3
Tangible book$3.83B
Net cash-$2.43B
Current ratio0.8
Debt/Equity0.6
ROA-15.7%
ROE-36.2%
Cash conversion8.0%
CapEx/Revenue-3.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000822Activity
Op margin-27.8%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-29.2%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin-5.7%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity64.0%59.0% medp25 54.9% · p75 72.9%above median
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 03:46 UTCJob: f4ff8132